These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7505905)

  • 21. Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis.
    Garbar C; Jadoul M; Noël H; van Ypersele de Strihou C
    Kidney Int; 1999 May; 55(5):1983-90. PubMed ID: 10231463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta 2-microglobulin metabolism in uremic patients who are undergoing dialysis.
    Chanard J; Vincent C; Caudwell V; Lavaud S; Toupance O; Wong T; Revillard JP
    Kidney Int Suppl; 1993 Jun; 41():S83-7. PubMed ID: 8320953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.
    Iida Y; Miyata T; Inagi R; Sugiyama S; Maeda K
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1235-41. PubMed ID: 8024566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum amyloid P component: a predictor of clinical beta 2-microglobulin amyloidosis.
    Spiegel DM; Sprague SM
    Am J Kidney Dis; 1992 May; 19(5):427-32. PubMed ID: 1585929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quantitation and heterogeneity of serum alpha 2-macroglobulin].
    Mashiko T; Ichikawa K; Jimbo S; Tanaka T; Kanoh Y; Ohtani H
    Rinsho Byori; 1999 May; 47(5):473-8. PubMed ID: 10375970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum.
    Niwa T; Katsuzaki T; Momoi T; Miyazaki T; Ogawa H; Saito A; Miyazaki S; Maeda K; Tatemichi N; Takei Y
    Kidney Int; 1996 Mar; 49(3):861-7. PubMed ID: 8648931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Zoga M; Alevyzaki F; Stamatelou K; Frangou E; Savva L; Nicolaou C
    Nephrology (Carlton); 2006 Dec; 11(6):506-9. PubMed ID: 17199788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha 2-macroglobulin and pregnancy zone protein. Serum levels, alpha 2-macroglobulin receptors, cellular synthesis and aspects of function in relation to immunology.
    Petersen CM
    Dan Med Bull; 1993 Sep; 40(4):409-46. PubMed ID: 7693397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E and alpha 1-antichymotrypsin in dialysis-related amyloidosis.
    Gejyo F; Kimura H; Suzuki S; Miyazaki R; Naiki H; Nakakuki K
    Kidney Int Suppl; 1997 Nov; 62():S75-8. PubMed ID: 9350687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. alpha2-Macroglobulin, the main serum antiprotease, binds beta2-microglobulin, the light chain of the class I major histocompatibility complex, which is involved in human disease.
    Gouin-Charnet A; Laune D; Granier C; Mani JC; Pau B; Mourad G; Argilés A
    Clin Sci (Lond); 2000 Apr; 98(4):427-33. PubMed ID: 10731476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiovascular risk markers in hemodialysis].
    Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
    G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
    Díez JJ; Iglesias P; Fernández-Reyes MJ; Aguilera A; Bajo MA; Alvarez-Fidalgo P; Codoceo R; Selgas R
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A circulating beta 2-microglobulin intermediate in hemodialysis patients.
    Uji Y; Motomiya Y; Ando Y
    Nephron Clin Pract; 2009; 111(3):c173-81. PubMed ID: 19194107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years.
    Otsubo S; Kimata N; Okutsu I; Oshikawa K; Ueda S; Sugimoto H; Mitobe M; Uchida K; Otsubo K; Nitta K; Akiba T
    Nephrol Dial Transplant; 2009 May; 24(5):1593-8. PubMed ID: 19096084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients.
    Michelis R; Sela S; Ben-Zvi I; Nagler RM
    Blood Purif; 2007; 25(5-6):505-9. PubMed ID: 18187941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of uremic and endothelial factors in the development of beta 2-microglobulin amyloidosis.
    Nakashima Y; Akizawa T; Nagai T; Koshikawa S
    Kidney Int Suppl; 1993 Jun; 41():S88-95. PubMed ID: 8320954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
    Miyata T; Oda O; Inagi R; Iida Y; Araki N; Yamada N; Horiuchi S; Taniguchi N; Maeda K; Kinoshita T
    J Clin Invest; 1993 Sep; 92(3):1243-52. PubMed ID: 8376584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C1Q complexes with beta-2-microglobulin and amyloid P-component in sera of patients with dialysis-associated amyloidosis.
    Hasegawa M; Kawashima S; Shikano M; Kojima K; Yanai T; Hassegawa H; Tomita M; Murakami K; Kawamura N; Katsumata H
    Nephron; 1995; 69(4):380-3. PubMed ID: 7777100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.